Evidence map›Paper›PMID 29997176›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation.

Subhalakshmi Sharma, Kateřina Čermáková, Jan De Rijck, Jonas Demeulemeester, Milan Fábry, Sara El Ashkar, Siska Van Belle, Martin Lepšík, Petr Tesina, Vojtěch Duchoslav and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 3 countries.

Subhalakshmi SharmaMolecular Virology and Gene Therapy, KU Leuven, 3000 Leuven, Belgium.
Kateřina ČermákováInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 166 10 Prague 6, Czech Republic.
Jan De RijckMolecular Virology and Gene Therapy, KU Leuven, 3000 Leuven, Belgium; jan.derijck@kuleuven.be zeger.debyser@kuleuven.be veverka@uochb.cas.cz.
Jonas DemeulemeesterMolecular Virology and Gene Therapy, KU Leuven, 3000 Leuven, Belgium.
Milan FábryInstitute of Molecular Genetics of the Czech Academy of Sciences, 142 20 Prague 4, Czech Republic.
Sara El AshkarMolecular Virology and Gene Therapy, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0001-9410-5687
Siska Van BelleMolecular Virology and Gene Therapy, KU Leuven, 3000 Leuven, Belgium.
Martin LepšíkInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 166 10 Prague 6, Czech Republic.
Petr TesinaInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 166 10 Prague 6, Czech Republic.
Vojtěch DuchoslavInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 166 10 Prague 6, Czech Republic.
Petr NovákInstitute of Microbiology of the Czech Academy of Sciences, 142 20 Prague 4, Czech Republic.
Martin HubálekInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 166 10 Prague 6, Czech Republic.
Pavel SrbInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 166 10 Prague 6, Czech Republic.
Frauke ChristMolecular Virology and Gene Therapy, KU Leuven, 3000 Leuven, Belgium.
Pavlína ŘezáčováInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 166 10 Prague 6, Czech Republic.
H Courtney HodgesDepartment of Molecular & Cellular Biology, Baylor College of Medicine, Houston, TX 77030.ORCID 0000-0003-4441-497X
Zeger DebyserMolecular Virology and Gene Therapy, KU Leuven, 3000 Leuven, Belgium; jan.derijck@kuleuven.be zeger.debyser@kuleuven.be veverka@uochb.cas.cz.
Václav VeverkaInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 166 10 Prague 6, Czech Republic; jan.derijck@kuleuven.be zeger.debyser@kuleuven.be veverka@uochb.cas.cz.
KU Leuven · BECzech Academy of Sciences, Institute of Organic Chemistry and Biochemistry · CZCzech Academy of Sciences, Institute of Molecular Genetics · CZBaylor College of Medicine · USCharles University · CZCzech Academy of Sciences · CZThe University of Texas MD Anderson Cancer Center · US

Funding

Dynamic effects of cancer mutations on the mammalian SWI/SNF ATPase BrgR00CA187565 · NCI · BAYLOR COLLEGE OF MEDICINE · PI HODGES, HAMILTON COURTNEY · 2017 to 2019
$747k
NCI NIH HHS R00 CA187565
6 · The paper itself

Abstract

Lens epithelium-derived growth factor/p75 (LEDGF/p75, or PSIP1) is a transcriptional coactivator that tethers other proteins to gene bodies. The chromatin tethering function of LEDGF/p75 is hijacked by HIV integrase to ensure viral integration at sites of active transcription. LEDGF/p75 is also important for the development of mixed-lineage leukemia (MLL), where it tethers the MLL1 fusion complex at aberrant MLL targets, inducing malignant transformation. However, little is known about how the LEDGF/p75 protein interaction network is regulated. Here, we obtained solution structures of the complete interfaces between the LEDGF/p75 integrase binding domain (IBD) and its cellular binding partners and validated another binding partner, Mediator subunit 1 (MED1). We reveal that structurally conserved IBD-binding motifs (IBMs) on known LEDGF/p75 binding partners can be regulated by phosphorylation, permitting switching between low- and high-affinity states. Finally, we show that elimination of IBM phosphorylation sites on MLL1 disrupts the oncogenic potential of primary MLL1-rearranged leukemic cells. Our results demonstrate that kinase-dependent phosphorylation of MLL1 represents a previously unknown oncogenic dependency that may be harnessed in the treatment of MLL-rearranged leukemia.

Indexed as

Adaptor Proteins, Signal TransducingAmino Acid MotifsCell Line, TumorHistone-Lysine N-MethyltransferaseHIVHIV IntegraseHumansMediator Complex Subunit 1Myeloid-Lymphoid Leukemia ProteinPhosphorylationTranscription FactorsAdaptor Proteins, Signal TransducingHistone-Lysine N-MethyltransferaseHIV IntegraseKMT2A protein, humanMED1 protein, humanMediator Complex Subunit 1Myeloid-Lymphoid Leukemia ProteinPSIP1 protein, humanTranscription Factorsdisordered proteinsLEDGF/p75leukemiaphosphorylationprotein–protein interactions

Identifiers

PMID29997176
PMCPMC6065015
OpenAlexW2835153656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.